Perlindungan Hukum Bagi Konsumen terhadap Penggunaan Vaksin Campak Rubella Berdasarkan Hukum Positif di Indonesia
DOI:
https://doi.org/10.47679/ib.2023459Keywords:
Konsumen, Perlindungan Hukum, Vaksin, Campak RubellaAbstract
References
Bella, A. (2022). Memahami Jenis dan Kandungan Vaksin Beserta Manfaatnya. Diakses dari https://www.alodokter.com/memahami-vaksin-berdasarkan-kandungannya.
Biro Komunikasi dan Pelayanan Masyarakat Kementerian Kesehatan RI dan Tim Komunikasi Pemerintah Kemkominfo. (2017). Imuniasi Campak dan Rubella untuk Penuhi Hak Anak Indonesia. Diakses dari https://www.kemenpppa.go.id/index.php/page/read/29/1463/imuniasi-campak-dan-rubella-untuk-penuhi-hak-anak-indonesia.
Elisabeth. (2017). Diakses dari http://p2p.kemkes.go.id/wp-content/uploads/2017/12/.
Fatwa Majelis Ulama Indonesia Nomor 33 Tahun 2018 Tentang Penggunaan Vaksin MR (Measles Rubella) Produk Dari SII (Serum Institute of India) Untuk Imunisasi.
Fauzia, A., & Hamdani, F. (2021a). Pendekatan Socio-Cultural dalam Pelaksanaan Vaksinasi Covid-19 di Indonesia. Seminar Nasional Hukum Universitas Negeri Semarang, 7(1).
Fauzia, A., & Hamdani, F. (2021b). Sanksi Penundaan atau Penghentian Jaminan Sosial Pada Masa Pandemi COVID-19. Jurnal Kajian Pembaruan Hukum, 1(2).
Fauzia, A., & Hamdani, F. (2021c). Aktualisasi nilai-nilai pancasila dan konstitusi melalui pelokalan kebijakan Hak Asasi Manusia (HAM) di daerah. Jurnal Indonesia Berdaya, 2(2).
Gunawan, J. 1999. Hukum Perlindungan Konsumen. Universitas Katolik Parahyangan. Bandung.
Hadikusumah, H. H. 2004. Pengantar Antropologi Hukum. Citra Aditya Bakti. Bandung.
Ibrahim, J. 2005. Teori & Metodologi Penelitian Hukum Normatif. Banyumedia Publishing. Malang.
Indonesia. Undang-Undang Tentang Perlindungan Konsumen, UU No. 8 Tahun 1999. LN No.42 Tahun 1999. TLN No. 3821.
Indonesia. Peraturan Pemerintah tentang Lembaga Perlindungan Konsumen Swadaya Masyarakat, PP No. 59 Tahun 2001. TLN No. 4127.
Kamil, I. (2022). Vaksin Covid-19 dari Gavi Masuk Februari: Indonesia Minimal dapat 54 Juta Dosis. Diakses dari https://nasional.tempo.co/read/1422223/vaksin-covid-19-dari-gavi-masuk-februari-indonesia-minimal-dapat-54-juta-dosis.
Krisiyanti, C. T. S. 2014. Hukum Perlindungan Konsumen. PT. Sinar Grafika. Jakarta.
Maranti, I. U. A. (2019). Perlindungan Hukum Konsumen dalam Penggunaan Vaksinasi Campak Rubella Berdasarkan Hukum Positif di Indonesia. Artikel Ilmiah.
Mulyadi, A. (2017). Diakses dari http://p2p.kemkes.go.id/wp-content/uploads/2017/12/.
Ridwan, A. (2016). Diakses dari http:///penyakit_campak_dan_rubella, Ditjen P2P.
Shofie, Y. 2003. Penyelesaian Sengketa Konsumen menurut Undang-Undang Perlindungan Konsumen (UUPK), Teori dan Praktek Penegakan Hukum. PT. Citra Aditya Bakti. Mataram.
Sundari, S. S. A. (2019). Hukum Perlindungan Konsumen Terhadap Pengguna Vaksin Measles Ruella (MR) Perspektif Ibnu Taimiyah. Skripsi, Universitas Islam Negeri Sumatera Utara.
Walter, S. (2008). Perlindungan Hukum terhadap Konsumen Atas Peredaran dan Penggunaan Vaksin. Analisis Standar Pelayanan Minimal Pada Instalasi Rawat Jalan di RSUD Kota Semarang, 3.
Yanuarta, A. Diakses dari https:///www.bbc.com/indonesia.
Downloads
Published
How to Cite
Issue
Section
Citation Check
License
Copyright and License Agreement
In submitting the manuscript to the journal, the authors certify that:
- They are authorized by their co-authors to enter into these arrangements.
- The work described has not been formally published before, except in the form of an abstract or as part of a published lecture, review, thesis, or overlay journal. Please also carefully read BIB's Posting Your Article Policy at https://www.ukinstitute.org/journals/ib/about/editorialPolicies#custom-3
- That it is not under consideration for publication elsewhere,
- That its publication has been approved by all the author(s) and by the responsible authorities tacitly or explicitly of the institutes where the work has been carried out.
- They secure the right to reproduce any material that has already been published or copyrighted elsewhere.
- They agree to the following license and copyright agreement.
Copyright
Authors who publish with Journal of Indonesia Berdaya agrees to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under an Attribution-ShareAlike 4.0 International (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
Licensing for Data Publication
Journal of Indonesia Berdaya use a variety of waivers and licenses, that are specifically designed for and appropriate for the treatment of data:
- Open Data Commons Attribution License, http://www.opendatacommons.org/licenses/by/1.0/ (default)
- Creative Commons CC-Zero Waiver, http://creativecommons.org/publicdomain/zero/1.0/
- Open Data Commons Public Domain Dedication and Licence, http://www.opendatacommons.org/licenses/pddl/1-0/
Other data publishing licenses may be allowed as exceptions (subject to approval by the editor on a case-by-case basis) and should be justified with a written statement from the author, which will be published with the article.

Journal of Indonesia Berdaya is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.